# The FARAPULSE FARA-Freedom Trial

> **NCT05072964** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 180 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** FARAPULSE Pulsed Field Ablation System

## Key facts

- **NCT ID:** NCT05072964
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-21
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-10-19
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05072964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05072964, "The FARAPULSE FARA-Freedom Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05072964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*